Inspire Medical CPO awarded 15,958 RSUs

Inspire Medical Systems reported that Chief People Officer Melissa Mann acquired 15,958 shares of common stock through a grant of restricted stock units.

Accepted by SEC EDGAR 02/24/2026 - 07:05 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Inspire Medical Systems reported that Chief People Officer Melissa Mann acquired 15,958 shares of common stock through a grant of restricted stock units. These RSUs vest in three equal annual installments starting on February 20, 2027. Each RSU converts into one common share if she remains employed through each vesting date.

Insider Trade Summary

Grant/Award: 15,958 shares

Grant/Award 1 txn

Insider Mann Melissa

Role Chief People Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	15,958	$0.00	$0.00

Holdings After Transaction: Common Stock — 23,609 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Inspire Medical Systems (INSP) report for Melissa Mann?

Inspire Medical Systems reported that Chief People Officer Melissa Mann acquired 15,958 shares via a restricted stock unit grant. The RSUs represent compensation that converts into common stock over time, aligning a portion of her pay with future company performance and continued employment.

How many restricted stock units were granted to the Inspire Medical Systems CPO?

Melissa Mann received a grant of 15,958 restricted stock units of Inspire Medical Systems common stock. Each RSU represents a contingent right to one share, subject to a multi-year vesting schedule and her continued employment with the company through the specified vesting dates.

What is the vesting schedule for Melissa Mann’s 15,958 RSUs at Inspire Medical Systems (INSP)?

The 15,958 RSUs granted to Melissa Mann vest in three equal annual installments starting February 20, 2027. Each year, one-third of the RSUs is scheduled to vest, provided she remains continuously employed with Inspire Medical Systems through each relevant vesting date.

Do Melissa Mann’s RSUs at Inspire Medical Systems have an exercise price?

The reported RSU grant to Melissa Mann carries a transaction price per share of $0.00 because restricted stock units typically do not require an exercise payment. Instead, they convert into shares of common stock upon vesting if the employment-based vesting conditions are satisfied.

How many Inspire Medical Systems shares does Melissa Mann hold after this RSU grant?

Following the reported transaction, Melissa Mann is shown as beneficially owning 23,609 shares of Inspire Medical Systems common stock. This figure reflects her direct ownership after the award of 15,958 restricted stock units reported in the Form 4 insider transaction filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mann Melissa

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		15,958(1)	A	$0.00	23,609	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.

	/s/ Bryan Phillips, Attorney-in-Fact for Melissa Mann	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.